AstraZeneca and Oracle plan AI partnership for clinical trial recruitment

First reported by Wall Street Journal at · Updated · 2 sources

The companies aim to use real patient health data to identify potential trial participants faster, according to The Next Web. The publisher reports that they signed a non-binding term sheet, leaving the terms unfinished. The collaboration adds to other AI partnerships between pharmaceutical and technology companies.

Covered by 2 publishers within 5 hours of the first report.

Reporting2

Wall Street Journal AstraZeneca Partners With Oracle to Refine Clinical Research With AI · Adrià Calatayud
The Next Web AstraZeneca and Oracle team up on AI to find patients for drug trials · Alina Maria Stan

Related

Topics Oracle